Echo IQ secures FDA clearance for AI software
Echo IQ (ASX:EIQ) has reported notable progress in its quarterly update for the period ending 30 September 2024. The company secured 510(k) clearance from the US Food and Drug Administration (FDA) for its EchoSolv-AS software. This allows Echo IQ to market its technology to healthcare professionals in the United States. The company also announced a […]
Echo IQ secures FDA clearance for AI software Read More »







